Notably, the AJCC TNM staging system omits several pertinent clinical factors that may impact the prognosis of colon cancer, including tumor grade and carcinoembryonic antigen (CEA) levels (6, 7). This evidence concerns the gene CEACAM5 and colonic neoplasm.